EndoflipTM 300 System
K-Number: K231861 · 2023-07-21
ApplicantCovidien, LLC
Decision Date2023-07-21
Product CodeFFX
Advisory CommitteeGU
DecisionSubstantially Equivalent
Device Summary
EndoflipTM 300 System is a medical device manufactured by Covidien, LLC. It received FDA 510(k) clearance on 2023-07-21 under approval number K231861. The device is classified under product code FFX. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the EndoflipTM 300 System?
EndoflipTM 300 System is a medical device that received FDA 510(k) clearance on 2023-07-21. It is manufactured by Covidien, LLC. The 510(k) number is K231861.
When was EndoflipTM 300 System approved by the FDA?
EndoflipTM 300 System received FDA 510(k) clearance on 2023-07-21, under approval number K231861.
What company makes EndoflipTM 300 System?
EndoflipTM 300 System is manufactured by Covidien, LLC.
What is the FDA product code for EndoflipTM 300 System?
The FDA product code for EndoflipTM 300 System is FFX.
Other Devices by Covidien, LLC
Related Devices (Code: FFX)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.